CN Stock MarketDetailed Quotes

688331 RemeGen Co., Ltd.

Watchlist

31.92
-0.93-2.83%

Market Closed Dec 20 15:00 CST

17.38BMarket Cap-11.20P/E (TTM)

RemeGen Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RemeGen Co., Ltd. FY2024 9-Month Earnings Date

Currency：CNYOct 29, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	1.21B	--
		+57.10%
EPS	--	-1.99	--
		-4.19%

Analyst Rating

Strong Buy

Dec 22, 2024

RemeGen Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.422B	--
--	2024/FY	-- / 1.727B	--
--	2023/FY	1.083B / 1.129B	--
Mar 30, 2023	2022/FY	772.109M / 870.124M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.422B--

--2024/FY-- / 1.727B--

--2023/FY1.083B / 1.129B--

Mar 30, 20232022/FY772.109M / 870.124M--

--------

Unlock Free Earnings Estimates

Open Account

RemeGen Co., Ltd. Earnings Reports

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 Third Quarter Report

Oct 30 00:00

Remegen Biopharmaceutical (Yantai) Co., Ltd. 2024 Semi-annual Report

Aug 17 00:00

Summary of Remegen (Yantai) Co., Ltd.'s 2024 Interim Report

Aug 17 00:00

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 First Quarter Report

Apr 27 00:00

Top CN Stock Gainers

Symbol Price % Chg

Zhejiang Lanyu Digital Technology

Hangzhou Raycloud Technology Co.,Ltd

688365

13.90 +20.03%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Strong Buy

Strong Buy
85.71%
Buy
7.14%
Hold
7.14%
Underperform
0.00%
Sell
0.00%

Price Target

No Data